Currently, there is no clear evidence showing sermorelin is linked to developing cancer
This shift reflects a major change in legal and regulatory risk, driven by federal enforcement priorities, recent proposed legislation, and aggressive intellectual property enforcement by pharmaceutical companies that hold FDA approvals for GLP-1 drugs
Multicenter, placebo-controlled trial of lorcaserin for weight management
Despite identical food intake and fasting at endpoint, while WM-CR did not alter cecal content mass compared to Veh controls, incretin agonism significantly elevated cecal content weight at endpoint
The turmeric component is generally safe but may cause mild stomach upset in sensitive individuals
If gastrointestinal side effects such as nausea or early satiety are severe, the FDA label recommends delaying dose escalation or temporarily maintaining the current dose until symptoms improve